Initial and Subsequent DMT Choices in the Management of Multiple Sclerosis - a podcast by ReachMD

from 2021-03-17T00:00

:: ::

CME credits: 0.25

Valid until: 17-03-2022

Claim your CME credit at https://reachmd.com/programs/cme/initial-and-subsequent-dmt-choices-in-the-management-of-multiple-sclerosis/12350/



Treatment goals for patients with multiple sclerosis continue to be refined as more and better disease-modifying drugs emerge from clinical trials and we accrue findings from real-world data. Nonetheless, the decision to match a patient with a particular drug agent has become more complex as we strive to achieve our treat-to-target goals and optimize patient outcomes.

Drs. Coyle and Oh discuss how clinicians can best approach the medical management of patients with multiple sclerosis, both in the short and long term. The goal is to apply best clinical evidence while personalizing a patient’s therapy, thus offering the patient as normal a life as possible.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD